Enhanced exclusive enteral nutrition delivery during the first 7 days is associated with decreased 28-day mortality in critically ill patients with normal lactate level: a post hoc analysis of a multicenter randomized trial

Table 1 Baseline characteristics and clinical outcomes of study patients

	Total n = 1322
Age, y	64 (49–76)
BMI, kg/m²	22.5 (20.8–24.5)
Male	873 (66)
APACHE II	18 (14–23)
SOFA	7 (5–10)
mNUTRIC score	4 (3–6)
Number of co-morbidities	2 (1–3)
Lactate, mmol/L	1.8 (1.2–3)
ICU admission type
General	1143 (86.5)
Emergency	105 (7.9)
Surgical	53 (4)
Medical	21 (1.6)
Study intervention
Guideline group	822 (62.2)
Control group	500 (37.8)
Organ support therapy at enrollment
CRRT	141 (10.7)
Mechanical ventilation	844 (63.8)
Vasoactive agents	398 (30.1)
Clinical outcome
28-day mortality	175 (13.2)
ICU-free day to 28 days	6 (0–18)

Data are presented as n (%) or median (interquartile range)
BMI, Body Mass Index; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; mNUTRIC, modified Nutrition Risk in the Critically ill; and CRRT, Continuous Renal Replacement Therapy

ISSN: 1364-8535